Skip to the page

Data / Form D filings / Xylogenics, Inc.

Xylogenics, Inc.: Form D filings

Xylogenics, Inc., a biotechnology company in Indianapolis, IN, filed 2 Form D notices with the SEC in 2010. The latest, on December 20, 2010, reports $300,000 sold of a $350,000 offering to 9 investors.

Find out what Xylogenics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
351 WEST 10TH STREET, SUITE 326, Indianapolis, IN, 46202
Phone
(317) 697-7514
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Indiana
Year incorporated
2008
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506
SEC identifier (CIK)
1489404

The full lists. Form D filings in Indiana: 436 rows, $21.80, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 20, 2010New notice$350,000$300,000$50,0009Jul 27, 2010sec.gov
May 13, 2010New notice$350,000$225,000$125,0006Feb 12, 2010sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Butch MercerExecutive Officer
Mike NeiblerExecutive Officer

Other biotechnology companies in Indiana that filed recently

Every Form D from the week of Dec 20, 2010 · All recent filings in Indiana · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Xylogenics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.

$10 of credit on sign-up, no card.